Rightway Secured $155 Million in Series E Funding

The pharmacy benefits and care navigation firm will use the new capital to scale its AI technology.

Updated on Sept. 25, 2026 in Healthcare

Rightway Secured $155 Million in Series E Funding

Live Poll

Do you feel your employer-provided pharmacy benefits are becoming more affordable for your household?

Rightway has raised $155 million in a Series E funding round led by Francisco Partners. The company provides pharmacy benefit management and care navigation services to 45 Fortune 500 clients.

Why it matters

The capital injection will support the expansion of Rightway's pharmacy benefits technology and AI capabilities aimed at streamlining pharmacist workflows. Rightway maintains a transparent model that passes all rebates directly to clients while utilizing its SureSpend pricing model to control pharmacy spending.

The company secured $155 million in Series E funding, building on its previous $108.75 million Series D raise in 2024. Rightway currently serves 45 Fortune 500 companies as clients.

The players

Rightway

This company provides pharmacy benefit management and care navigation services for corporate employers.

Francisco Partners

This global investment firm specializes in partnering with technology and technology-enabled services companies.

Thrive Capital

This venture capital firm focuses on internet and software investments.

Khosla Ventures

This venture capital firm provides early-stage and growth-stage funding for companies in various technology sectors.

The details

Rightway operates a unique model where it does not own pharmacies, instead charging an administrative fee per member while passing all rebates to its clients. The firm leverages backend AI and embeds clinicians directly into the workflow to manage prescription costs and choices.

Timeline

  1. Rightway was founded in 2017 with $2 million in seed funding.

  2. The company secured $20 million in Series B financing in 2019.

  3. Rightway raised $100 million in Series C funding in 2021.

  4. The firm secured $108.75 million in Series D financing in 2024.

  5. The $155 million Series E funding was announced on September 24, 2026.

Market Landscape

Rightway's model reflects the broader industry shift toward transparent pharmacy benefit management that avoids traditional profit centers like pharmacy ownership. This positioning directly challenges legacy PBM providers by focusing on administrative fee models that prioritize cost control for large corporate clients.

Employees at companies that switch to Rightway may see changes in their prescription drug coverage and pharmacy options as their employer adopts new benefit management technology. Because Rightway passes all rebates to clients, these companies may experience lower pharmacy spending, potentially affecting employee benefit plan pricing.

The takeaway

Rightway continues to gain traction by utilizing AI and clinician-led navigation to modernize how corporate employers manage pharmacy expenses. Employers looking to optimize healthcare spending may benefit from these transparent, tech-driven pharmacy management alternatives.

Further reading

For additional context on the sector, visit the Healthcare section.

Live Poll

Do you feel your employer-provided pharmacy benefits are becoming more affordable for your household?